Format

Send to

Choose Destination
JAMA Intern Med. 2016 Sep 1;176(9):1323-4. doi: 10.1001/jamainternmed.2016.3389.

Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently Unfair.

Author information

1
Division of General Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania2Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania3Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
2
Division of General Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania2Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania3Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania4Pharmacy Benefits Management Services, US Department of Veterans Affairs, Hines, Illinois5Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
PMID:
27367570
DOI:
10.1001/jamainternmed.2016.3389
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center